C. Chrubasik

661 total citations
18 papers, 499 citations indexed

About

C. Chrubasik is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, C. Chrubasik has authored 18 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Complementary and alternative medicine and 4 papers in Pharmacology. Recurrent topics in C. Chrubasik's work include Plant Toxicity and Pharmacological Properties (4 papers), Medicinal plant effects and applications (3 papers) and Complementary and Alternative Medicine Studies (3 papers). C. Chrubasik is often cited by papers focused on Plant Toxicity and Pharmacological Properties (4 papers), Medicinal plant effects and applications (3 papers) and Complementary and Alternative Medicine Studies (3 papers). C. Chrubasik collaborates with scholars based in Germany, Australia and Israel. C. Chrubasik's co-authors include S. Chrubasik, Ulf Müller‐Ladner, Basil D. Roufogalis, George Li, Rujee K. Duke, T. A. Torda, Andy Black, Raymond L. Jacobson, Thorsten J. Maier and Thomas Hofmann and has published in prestigious journals such as Phytotherapy Research, Phytomedicine and Swiss Medical Weekly.

In The Last Decade

C. Chrubasik

17 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Chrubasik Germany 10 217 144 137 135 74 18 499
Ana Alimpić Aradski Serbia 13 203 0.9× 249 1.7× 217 1.6× 111 0.8× 91 1.2× 36 452
Felipe Ávila Chile 14 217 1.0× 128 0.9× 133 1.0× 131 1.0× 36 0.5× 35 605
Hasret Yardibi Türkiye 8 127 0.6× 190 1.3× 112 0.8× 105 0.8× 70 0.9× 32 571
Vladimir Čanadanović Serbia 9 193 0.9× 156 1.1× 312 2.3× 78 0.6× 47 0.6× 25 558
Otto Mykkänen Finland 8 219 1.0× 167 1.2× 93 0.7× 146 1.1× 50 0.7× 9 688
Hichem Ben Salah Tunisia 13 97 0.4× 164 1.1× 139 1.0× 105 0.8× 37 0.5× 30 446
Sanghae Nam South Korea 10 175 0.8× 198 1.4× 197 1.4× 168 1.2× 31 0.4× 31 501
Ada Brambilla Italy 14 288 1.3× 165 1.1× 228 1.7× 82 0.6× 35 0.5× 21 632
Suzana Branković Serbia 15 147 0.7× 322 2.2× 266 1.9× 147 1.1× 70 0.9× 48 566
Оксана Головинская Russia 10 119 0.5× 87 0.6× 76 0.6× 138 1.0× 55 0.7× 18 502

Countries citing papers authored by C. Chrubasik

Since Specialization
Citations

This map shows the geographic impact of C. Chrubasik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chrubasik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chrubasik more than expected).

Fields of papers citing papers by C. Chrubasik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chrubasik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chrubasik. The network helps show where C. Chrubasik may publish in the future.

Co-authorship network of co-authors of C. Chrubasik

This figure shows the co-authorship network connecting the top 25 collaborators of C. Chrubasik. A scholar is included among the top collaborators of C. Chrubasik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Chrubasik. C. Chrubasik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chrubasik, S., et al.. (2015). Impact of risk factors on cardiovascular risk: a perspective on risk estimation in a Swiss population. Swiss Medical Weekly. 145(3738). w14180–w14180. 1 indexed citations
2.
Chrubasik‐Hausmann, Sigrun, et al.. (2014). Comparisons of home and daytime ambulatory blood pressure measurements. BMC Cardiovascular Disorders. 14(1). 94–94. 7 indexed citations
3.
Chrubasik‐Hausmann, Sigrun, C. Chrubasik, Elena Neumann, & Ulf Müller‐Ladner. (2014). A Pilot Study on the Effectiveness of a Rose Hip Shell Powder in Patients Suffering from Chronic Musculoskeletal Pain. Phytotherapy Research. 28(11). 1720–1726. 11 indexed citations
4.
Chrubasik, C., George Li, & S. Chrubasik. (2010). The clinical effectiveness of chokeberry: a systematic review. Phytotherapy Research. 24(8). 1107–1114. 120 indexed citations
5.
Chrubasik, C. & Raymond L. Jacobson. (2010). The development of artemisinin resistance in malaria: reasons and solutions. Phytotherapy Research. 24(7). 1104–1106. 11 indexed citations
6.
Chrubasik, S., C. Chrubasik, Elena Neumann, & Ulf Müller‐Ladner. (2009). Zur antientzündlichen Wirksamkeit von Pulver aus der Hagebutte. Zeitschrift für Phytotherapie. 30(5). 227–231. 1 indexed citations
7.
Chrubasik, C., Thorsten J. Maier, Corinna Dawid, et al.. (2008). An observational study and quantification of the actives in a supplement with Sambucus nigra and Asparagus officinalis used for weight reduction. Phytotherapy Research. 22(7). 913–918. 28 indexed citations
8.
Chrubasik, C., et al.. (2008). A one‐year survey on the use of a powder from Rosa canina lito in acute exacerbations of chronic pain. Phytotherapy Research. 22(9). 1141–1148. 20 indexed citations
9.
Chrubasik, C., Basil D. Roufogalis, Ulf Müller‐Ladner, & S. Chrubasik. (2008). A systematic review on the Rosa canina effect and efficacy profiles. Phytotherapy Research. 22(6). 725–733. 167 indexed citations
10.
Chrubasik, S., et al.. (2007). Patient-perceived benefit during one year of treatment with Doloteffin®. Phytomedicine. 14(6). 371–376. 10 indexed citations
11.
Chrubasik, C., Andy Black, Ulf Müller‐Ladner, & S. Chrubasik. (2007). Impact of herbal medicines on physical impairment. Phytomedicine. 15(6-7). 536–539. 5 indexed citations
12.
Chrubasik, C., Basil D. Roufogalis, Ulf Müller‐Ladner, & S. Chrubasik. (2007). Systematic review on the Rosa canina effect and efficacy profiles. Focus on Alternative and Complementary Therapies. 12(s1). 14–14. 19 indexed citations
13.
Chrubasik, C., Rujee K. Duke, & S. Chrubasik. (2006). The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytotherapy Research. 20(1). 1–3. 78 indexed citations
14.
Chrubasik, S., et al.. (2006). Effectiveness and safety of a rose hip and seed powder in the treatment of low back pain. Focus on Alternative and Complementary Therapies. 11(s1). 11–11. 1 indexed citations
15.
Chrubasik, S., C. Chrubasik, T. A. Torda, & Ahmed Madisch. (2005). Efficacy and tolerability of potato juice in dyspeptic patients: A pilot study. Phytomedicine. 13(1-2). 11–15. 16 indexed citations
16.
Chrubasik, C., S. Chrubasik, Ahmed Madisch, & T. A. Torda. (2005). Efficacy and tolerability of potato juice in dyspeptic patients: a pilot study. Focus on Alternative and Complementary Therapies. 10(s1). 13–13.
17.
Chrubasik, S., C. Chrubasik, & T. A. Torda. (2005). Early impact of a combined dietary and cognitive‐behavioural strategy on body mass index, blood pressure and quality of life. Focus on Alternative and Complementary Therapies. 10(s1). 13–13. 1 indexed citations
18.
Chrubasik, C.. (2000). Pain therapy using herbal medicines. Der Gynäkologe. 33(1). 59–65. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026